about
Characterization of the Paracoccidioides Hypoxia Response Reveals New Insights into Pathogenesis Mechanisms of This Important Human Pathogenic FungusAspergillus fumigatus Trehalose-Regulatory Subunit Homolog Moonlights To Mediate Cell Wall Homeostasis through Modulation of Chitin Synthase Activity.Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression.Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infectionTwo C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus.mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.The Janus transcription factor HapX controls fungal adaptation to both iron starvation and iron excess.Aspergillus fumigatus Photobiology Illuminates the Marked Heterogeneity between Isolates.IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge.Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.RbdB, a Rhomboid Protease Critical for SREBP Activation and Virulence in Aspergillus fumigatus.Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic DevelopmentSniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.Aspergillus fumigatus virulence through the lens of transcription factors.Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death.Diverse Regulation of the CreA Carbon Catabolite Repressor in Aspergillus nidulans.In vivo veritas: Aspergillus fumigatus proliferation and pathogenesis--conditionally speaking.7th Advances Against Aspergillosis: Basic, diagnostic, clinical and therapeutic studies.Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi.Host-Derived Leukotriene B4 Is Critical for Resistance against Invasive Pulmonary Aspergillosis.Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses.Protein Kinase A and High-Osmolarity Glycerol Response Pathways Cooperatively Control Cell Wall Carbohydrate Mobilization inAn Ssd1 Homolog Impacts Trehalose and Chitin Biosynthesis and Contributes to Virulence in Aspergillus fumigatusCharacterizing the Pathogenic, Genomic, and Chemical Traits of , a Close Relative of the Major Human Fungal PathogenBiofilms: five-star accommodations for the aerobically challengedResponse to Comment on "Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death"Reducing Aspergillus fumigatus Virulence through Targeted Dysregulation of the Conidiation PathwayNatamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against Fusarium Species Ocular IsolatesFungal biofilm morphology impacts hypoxia fitness and disease progressionBeta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lungIf looks could kill: Fungal macroscopic morphology and virulence
P50
Q28551656-3DC5499F-F1A8-4322-A621-7B4C243ACC85Q33603815-AFFE32BA-F7F9-46C2-85F1-DF2455E8BA90Q33621006-22A80C99-566A-4272-8056-26D17B459887Q33956119-6C9955A5-5388-48B5-937D-B1F077A5B166Q34257883-B47B0D1F-1844-4B76-8C72-136ACB27D455Q34447311-017EBAF7-180D-43F2-91C9-57D11AEDEF9FQ34481477-DBEDB9FB-ABB7-4BA7-A49F-AFC533075F57Q34511507-43B4F92F-8298-4CDA-9FAB-9DEE9CBC3175Q34540829-D5B014A0-D052-4309-B18E-2262585BA3BEQ35023529-329766E0-148F-429F-9B8F-CB7F65FE65BBQ36705885-4672CCE9-4C00-41B7-9D14-07D54B828220Q36891197-08BC0625-1DD0-431E-BC17-97C5AC1A6691Q37617395-D6B5CF2B-AE32-438A-96C0-016C83A7C947Q38616379-6EC9C0D3-41F1-4842-A8AD-6DDCA948012AQ38851418-9E607BEC-47AD-4662-9269-621DE6B76C68Q39000001-33932C9B-1B5D-422F-B4A2-93F34561969EQ40061696-D9C0E90E-0911-46BA-AC63-97DC3C2D5BABQ41091197-14E9AEF3-6E1D-47F7-A7C6-9691002CCBE0Q42779024-A092C2CB-9E5C-40DB-99FA-A10B02061DDEQ45946960-374C816B-5FA4-4BC1-9698-772FF1152C3BQ46249593-37949C49-41FB-4F0F-9D33-237928C6B897Q47645930-16A1E2EF-EA80-42B2-A3AE-C2178C0F3571Q49921671-2646495C-2F76-44B9-A1A9-36AB8378A8A6Q50048770-3F6193E3-F889-4F10-8CD3-A8ED744528D0Q60303459-8635C05C-7C7E-4831-8977-750AB8D2787FQ64062420-48FF7A7E-0E5B-4EE1-AFAE-FF0B48297B17Q64263837-E8709FC4-0486-41F2-88C7-36136C4D7833Q86096749-25A4BFF1-865E-425D-8232-79A507E62814Q89181112-C0724CC9-0C0C-46F0-9B37-2060B98DAB8BQ89531384-3088BC98-4EC6-4A0D-A5CE-F615BA3EE08EQ90212824-340A65A9-8D13-44C5-8B19-515B46DCD90FQ90243007-721FC605-149B-4FE3-AEC4-DC1A677F8EA6Q91243790-921F9868-A6FA-4619-BDAB-19F8A9030C4BQ96578010-0B2C3818-210A-4757-BD46-0824ADE8EB1D
P50
description
researcher ORCID ID = 0000-0001-5503-5006
@en
wetenschapper
@nl
name
Robert Cramer
@ast
Robert Cramer
@en
Robert Cramer
@es
Robert Cramer
@nl
type
label
Robert Cramer
@ast
Robert Cramer
@en
Robert Cramer
@es
Robert Cramer
@nl
prefLabel
Robert Cramer
@ast
Robert Cramer
@en
Robert Cramer
@es
Robert Cramer
@nl
P106
P31
P496
0000-0001-5503-5006